Skip to main content
Figure 4 | Radiation Oncology

Figure 4

From: Pharmacokinetics and biodistribution of Erufosine in nude mice - implications for combination with radiotherapy

Figure 4

Urine excretion of Erufosine after repeated intraperitoneal drug injections. NMRI nu/nu mice were treated with intraperitoneal injection of 20 mg/kg body weight and 40 mg/kg body weight (n = 6 each) Erufosine every 48 hours for two weeks. The urine was collected over 24-hours on the last three consecutive days of the treatment period in a metabolic cage. Average urine volumes were determined and concentrations of Erufosine in urine were measured by using LC-MS/MS analysis. Data show (A) the urine concentrations and (B) the total amount of Erufosine (means ± SEM).

Back to article page

Radiation Oncology

ISSN: 1748-717X

Contact us